XML 57 R37.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Net revenues (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Revenue from Contract with Customer [Abstract] |
Disaggregation of Revenue | The following table disaggregates revenue by global product category for the years ended December 31, 2024, 2023 and 2022.
| Year Ended December 31,
| 2024 |  | 2023 |  | 2022 |  |
Vascular access | $ | 732,675 |  |  | $ | 708,044 |  |  | $ | 683,612 |  |  |
Interventional | 586,057 |  |  | 511,434 |  |  | 445,018 |  |  |
Anesthesia | 395,285 |  |  | 389,957 |  |  | 388,890 |  |  |
Surgical | 450,482 |  |  | 427,359 |  |  | 392,917 |  |  |
Interventional urology | 331,092 |  |  | 319,785 |  |  | 322,832 |  |  |
OEM | 344,511 |  |  | 326,008 |  |  | 272,624 |  |  |
Other (1) | 207,222 |  |  | 291,902 |  |  | 285,148 |  |  |
Net revenues (2) | $ | 3,047,324 |  |  | $ | 2,974,489 |  |  | $ | 2,791,041 |  |  |
(1) Includes revenues generated from sales of our respiratory and urology products (other than interventional urology products). (2) The product categories listed above are presented on a global basis, as each of our reportable segments is defined based on the geographic location of its operations.

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration